📰 Collaborative Group News
Page 13 - Collaborative Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Collaborative Group. Real-time updates on events, politics, business and more.
July 5, 2022
The discordant findings from observational studies and randomized clinical trials affect doctors decisions concerning hormone therapy for menopausal women.
May 16, 2022
A neurodegenerative disorder, Alzheimer's disease (AD), is characterized by dementia in which there is an age-related decline in cognition and higher functions. Stroke is a cerebrovascular disorder that frequently presents in old age and is a known risk factor for AD development. However, the association that AD can be a risk factor for stroke is not well-studied. This review article compiled various studies that pointed out the association between stroke development in patients with deme...
May 8, 2022
TodayHeadline Dairy Products Linked to Increased Risk of Cancer in Major Research Study - SciTechDaily –
March 9, 2022
Since 1979, the IMAP has convened leading experts in the field of SRHR and acted as an independent advisory body on SRHR topics and as strategic support to the Federation
March 7, 2022
07.03.2022 - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 07, 2022 (GLOBE NEWSWIRE) - (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has received a US$15 million milestone payment from AstraZeneca PLC (“AstraZeneca”) ...
January 31, 2022
UK: E Sammons, University of Oxford, Oxford, UK, and colleagues have found in a randomized controlled trial REVEAL that addition of cholesteryl ester transfer protein inhibitor therapy anacetrapib to...
November 30, 2021
Osimertinib will be made available via the Cancer Drugs Fund (CDF) to patients in England with completely resected early-stage IB-IIIA EGFR mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).1
November 24, 2021
— Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung cancer patients whose tumors harbor aberrations of...
September 17, 2021
中新社北京4月25日电 (记者 曾利明)由于玉树地区目前气温较低,御寒物资不足,灾区群众及参加抗震救灾人员易患上呼吸道感染疾病,急需抗感冒类药品。安徽济人药业有限公司今天通过中华中医药学会向灾区捐赠价值1000万元人民币的疏风解毒胶囊,从今天起陆续运抵灾区。 为指导灾区群众用药,中医临床专家奚肇庆教授讲解了该药品功能主治和临床应用特点。国家中医药�...